Home
About
News
Products
Solutions
Service & Support
Join Us
Industry Dynamics
Home News Industry Dynamics
Hundreds of Enterprises Participated in the Third Exchange for Quality Management of Medical Devices to Create the Brand of Medical Devices Made in China
Released on:2021-12-16

Source: news.sohu.com

     

On July 21, the "Third Meeting for Experience Exchange of Good Manufacturing Practice for Medical Devices" was held in Beijing. This meeting was guided by the Supervision Department and Center for Food and Drug Inspection of National Medical Products Administration, and undertaken by China Association for Medical Devices Industry. Themed on "safe use of device for innovative development", this meeting is aimed at further promoting the quality management consciousness of medical device enterprises, improving the management level and driving the medical device industry to develop at high quality. 

The "Third Meeting for Experience Exchange of Good Manufacturing Practice for Medical Devices" is held in order to improve the level of overall quality management system of the medical device industry, facilitate the high-quality development of the industry, and practically guarantee the safe use of devices among the public. This meeting got the high-quality medical device manufacturers recommended by the provincial (regional and municipal) drug administrations, so as to give full play to the demonstration effect of typical enterprises by virtue of the inter-enterprise communications and exchanges of advanced experiences. 


At this exchange meeting, representatives from many excellent medical device enterprises delivered their speeches to share their own valuable experiences in product quality control. Innovita (Tangshan) Biological Technology Co., Ltd. (hereinafter referred to as "INNOVITA"), an outstanding enterprise representative in the field of in vitro diagnostic reagents, introduced its idea and actions of quality control in various links including the design, production and improvement of products in detail at the meeting. 


 

 

Since the outbreak of COVID-19 epidemic in 2020, INNOVITA rapidly responded and urgently transferred its elites to step up scientific research and tackle the key research project night and day. Moreover, in dozens of days, INNOVITA has successfully developed 2019-nCoV Antibody Test Kit which was emergently approved by the National Medical Products Administration, and thus became the first batch of companies obtaining the registration certificate of 2019-nCoV Antibody Testing Reagent in the country. Its products sell well at home and abroad, making excellent contributions to the fight against COVID-19 epidemic. Besides, INNOVITA won the honor of "national advanced collective for fight against COVID-19" in the National Commendation Conference for Fight against COVID-19 in September 2020. On January 26 of this year, a letter of thanks from the Ministry of Science and Technology was especially sent to INNOVITA for its support in the emergency scientific research project of fight against COVID-19. 

 

Zhang Xiujie, Founder and Managing Director of INNOVITA, said: "Requirements on the high standard of quality management system and the production speed by 2019-nCoV test products all bring challenges to us, but also transforms into the force driving us to make accelerated progress and benefits us a lot. During this period, the whole staff has generally improved our quality consciousness, deeply understood that 'quality is the lifeline of an enterprise', and spontaneously devoted themselves to the quality management system. In this way, our product quality, and production and service efficiency thus stepped into a new stage. Accordingly, the Company's core competitiveness has been enhanced, with the market share of our products improved rapidly. " 


image.png

 

It is learned that INNOVITA currently has gradually perfected its quality management system of multiple links from design, production to customer services, and implement the quality management system throughout the whole life cycle of its products. They have profoundly realized that improving the quality management system of medical devices is to be responsible for the development of an enterprise, and even be responsible for the life and health of the people.